Media Resources

Media Resources

Recent News
Date Title
Oct 12, 2020
GBT Receives Rare Impact Award for Innovation from the National Organization for Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets.
Oct 05, 2020
GBT Announces New Employment Inducement Grants
Sep 09, 2020
GBT and Sickle Cell Disease Association of America to Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Sep 08, 2020
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern Countries
Sep 04, 2020
GBT Announces New Employment Inducement Grants
Media Resources

Media and Investor Contact

Steven Immergut
SVP, Head of Corporate Communications and Investor Relations
650-410-3258
simmergut@gbt.com